“…With the gradual expansion of electrospinning in pharmaceutics, its ability to convert dosage forms is drawing increasing attention ( Németh et al, 2022 ; Shokoya et al, 2023 ). The well-known unique properties of electrospun nanofibers (including small diameter, high porosity, large surface area, and simple fabrication) are showing merit for pharmaceutical applications, such as the amorphous state of drugs, their simple storage and good stability, fast dissolution, simple encapsulation of all kinds of active ingredients (oil, herbal medicines, proteins and peptides, and small chemical molecules), strong capability of synthesizing structural hybrids from a combination of filament-forming polymeric excipients, as well as excipients without electrospinnability (such as lipids, surfactants, and even inorganic materials), and the simple conversions of electrospun nanofibers as intermediate dosage forms to final medical products ( Weaver et al, 2022 ).…”